Baxion
Screening
Tags
Alerts
Theme
Kiora Pharmaceuticals Inc.
KPRX
·
NASDAQ
·
$2.70
Share Price as of 11/2
·
$12M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/07/26
10-Q
Q1 ended 03/31/26
05/08/26
10-K
FY 2025
03/25/26
10-Q
Q3 ended 09/30/25
11/07/25
10-Q
Q2 ended 06/30/25
08/08/25
Disclosures
Filter
8-K
Current report
10/29/26
8-K
Current report
09/08/26
8-K
Current report
08/19/26
8-K
Current report
08/07/26
8-K
Current report
06/18/26
Prospectuses and Registrations
Filter
424B3
Prospectus
05/28/26
S-3
Shelf registration
05/18/26
S-8
Registration of securities for employees
03/25/26
S-3
Shelf registration
09/15/25
S-8
Registration of securities for employees
03/25/25
Proxies
Filter
DEF 14A
Definitive proxy
04/30/26
DEF 14A
Definitive proxy
04/30/25
DEF 14A
Definitive proxy
03/25/24
PRE 14A
Preliminary proxy
03/15/24
DEFA14A
Additional proxy materials
09/01/23
Ownership
Filter
Form 3
Initial insider ownership
09/17/26
Form 4
Insider transaction
09/17/26
SC 13G
Beneficial ownership
09/17/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Other
Filter
EFFECT
Request for effectiveness
05/22/26
CORRESP
Correspondence with the SEC
05/20/26
UPLOAD
Letter from the SEC
05/20/26
ARS
Annual report to shareholders
05/01/26
D
D
04/21/26
Latest Filings
Filter
8-K
Current report
10/29/26
8-K
Current report
09/08/26
8-K
Current report
08/19/26
10-Q
Q2 ended 06/30/26
08/07/26
8-K
Current report
08/07/26
Ownership
Filter
Form 3
Initial insider ownership
09/17/26
Form 4
Insider transaction
09/17/26
SC 13G
Beneficial ownership
09/17/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26